Inhibitory Antibodies

抑制性抗体（Inhibitory Antibodies，常被称为中和抗体或阻断抗体）是一种能够特异性结合目标分子（如受体、酶或细胞因子），并直接抑制或阻断其正常生物学功能的特异性抗体。

货号 产品 反应 应用 偶联 引用
BF6100 Basiliximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6101 Sarilumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6102 Tocilizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6103 Ustekinumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6104 Ixekizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6105 Brodalumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6106 Itepekimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6107 Abrilumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6108 Vixarelimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6109 Denosumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6110 Elezanumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6111 Nirsevimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6112 Palivizumab Virus FACS, ELISA, Functional assay Unconjugated 0
BF6113 Clesrovimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6114 Suptavumab Virus FACS, ELISA, Functional assay Unconjugated 0
BF6115 Brentuximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6116 Datopotamab Human FACS, ELISA, Functional assay Unconjugated 0
BF6117 Tezepelumab (anti-TSLP) Human FACS, ELISA, Functional assay Unconjugated 0
BF6118 Blinatumomab Human FACS, ELISA, Functional assay Unconjugated 0
BF6119 Abituzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6120 Anifrolumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6121 Bapineuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6122 Bavituximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6123 Blosozumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6124 Codrituzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6125 Daclizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6126 Dalotuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6127 Dinutuximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6128 Drozitumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6129 Duligotuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6130 Dupilumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6131 Efalizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6132 Eldelumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6133 Enokizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6134 Epratuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6135 Farletuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6136 Fasinumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6137 Fezakinumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6138 Ficlatuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6139 Figitumumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6140 Fletikumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6141 Fulranumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6142 Galiximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6143 Ganitumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6144 Gantenerumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6145 Glembatumumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6146 Guselkumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6147 Imgatuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6148 Inotuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6149 Lampalizumab Human FACS, ELISA, Functional assay Unconjugated 0